© 2000 Kluwer Academic Publishers. Printed in the Netherlands. Original article Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC):

Phase II Study of Vinorelbine Plus Gemcitabine Options in Advanced Non-Small Cell Lung Cancer: A Review and Report on a doi: 10.1634/theoncologist.6-suppl_1-16

Rogerio Lilenbaum
Vinorelbine Plus Gemcitabine
Rogerio Lilenbaum
Key Words
Vinorelbine Gemcitabine
Lung Cancer

July 2015

located on the World Wide Web at: The online version of this article, along with updated information...

Original Articles Phase II Trial of Weekly Gemcitabine and Split-dose Cisplatin for Advanced Non-small-cell Lung Cancer

Atsushi Hiramatsu
Yoshinobu Iwasaki
Yasunori Koyama
Nobuyo Tamiya
Shigekuni Hosogi

January 2009

Objective: Cisplatin is widely used for the treatment of non-small-cell lung cancer. However, it can...

Efficacy of Gemcitabine Chemotherpy in Advanced Non-small cell Lung Cancer (NSCLC): A Phase II Study

라선영

January 1999

PURPOSE: To evaluate the efficacy and safety of gemcitabine, a pyrimidine antimetabolite against adv...

Cisplatin, Gemcitabine, and Vinorelbine Combination Therapy in Advanced Non–Small-Cell Lung Cancer: A Phase II Randomized Study of the Southern Italy Cooperative Oncology Group

Pasquale Comella
Nicola Panza
Luigi Manzione
Vito Lorusso
Gaetano Di Rienzo
Riccardo Cioffi
Luigi Maiorino
Domenico Bilancia
Gianpaolo Nicolella
Michele Natale
Franco Carpagnano
Carmen Pacilio
Mario De Lena
Andrea Bianco

October 2016

Purpose: In a previous phase I study cisplatin (CDDP), gemcitabine (GEM), and vinorelbine (VNR) comb...

A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIB/IV) non-small cell lung cancer

Chen, YM

[[abstract]]Study objective: Vinorelbine and gemcitabine are two active single agents used in the tr...

Original article

R. C. Lilenbaum
C. -s. Chen
T. Chidiac
P. O. Schwarzenberger
M. Thant
M. Versola
S. R. Lane

January 2004

Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanc...

Gemcitabine, vinorelbine, and cisplatin in the treatment of advanced nonsmall cell lung cancer

Hasturk S.
Hatabay N.
Ece F.
Karatasli M.
Hanta I.

January 2009

PubMedID: 19433960Objectives: Currently, cisplatin-based doublet combinations are accepted to be the...

Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: a multicenter phase II study.

Westeel, Virginie
Breton, J. L.
Braun, Daniel
Quoix, E.
Milleron, B.
Debieuvre, D.
Jacoulet, Pascale
Germa, C.
Kayitalire, L.
Depierre, A.

March 2006

International audienceIn this phase II study, gemcitabine and vinorelbine were combined at suboptima...

V. Lorusso
E. Crucitta
N. Panza
N. Silvestris
M. Guida
F. Carpagnano
S. Mancarella
D. Sambiasi
M. De Lena

January 2002

Background: The aim of our study was to determine the maximum tolerated dose of paclitaxel com-bined...

Combination chemotherapy of gemcitabine and vinorelbine for pretreated non-small- cell lung cancer: a retrospective study

Minami S
Ogata Y
Yamamoto S
Komuta K

September 2015

Seigo Minami, Yoshitaka Ogata, Suguru Yamamoto, Kiyoshi Komuta Department of Respiratory Medicine, O...

Clinical Trial Note A Phase II Study of Single-Agent Gemcitabine as a Second-Line Treatment in Advanced Non-Small Cell Lung Cancer

Yong Ho Roh
Seung-hyun Nam
Bong-seog Kim

January 2005

Objective: To evaluate the efficacy and safety of the single-agent gemcitabine in advanced non-small...

Efficacy of Gemcitabine Chemotherpy in Advanced Non-small cell Lung Cancer ( NSCLC ): A Phase 2 Study

김주항
노재경
장준

January 1999

PURPOSE: To evaluate the efficacy and safety of gemcitabine, a pyrimidine antimetabolite against adv...

Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy

Chen, YM

[[abstract]]Both gemcitabine and vinorelbine are new anticancer drugs that have shown activity in th...

Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Grossi F.
Jaskiewicz P.
Ferreira M.
Czyzewicz G.
Kowalski D.
Ciuffreda L.
Garcia-Gomez R.
Caruso S.
Bosch-Barrera J.
Gautier S.
Ta Thanh Minh C.
Henriet S.
de Castro G.

January 2021

Objective: The study investigated the efficacy and safety of oral vinorelbine-cisplatin (OV-CDDP) an...

Oral Vinorelbine for the Treatment of Metastatic Non-Small Cell Lung Cancer in Elderly Patients: A Phase II Trial of Efficacy and Toxicity.

Kanard, Anne
Jatoi, Aminah
Castillo, Rene
Geyer, Susan
Schulz, Thomas K
Fitch, Tom R, MD
Rowland, Kendrith M
Nair, Suresh G., MD
Krook, James E, MD
Kugler, John W, MD

March 2004

PURPOSE: Before now oral vinorelbine has not yet been tested in a cohort of elderly, advanced non-sm...

Phase II Study of Vinorelbine Plus Gemcitabine Options in Advanced Non-Small Cell Lung Cancer: A Review and Report on a doi: 10.1634/theoncologist.6-suppl_1-16

Rogerio Lilenbaum
Vinorelbine Plus Gemcitabine
Rogerio Lilenbaum
Key Words
Vinorelbine Gemcitabine
Lung Cancer

July 2015

located on the World Wide Web at: The online version of this article, along with updated information...

Original Articles Phase II Trial of Weekly Gemcitabine and Split-dose Cisplatin for Advanced Non-small-cell Lung Cancer

Atsushi Hiramatsu
Yoshinobu Iwasaki
Yasunori Koyama
Nobuyo Tamiya
Shigekuni Hosogi

January 2009

Objective: Cisplatin is widely used for the treatment of non-small-cell lung cancer. However, it can...

Efficacy of Gemcitabine Chemotherpy in Advanced Non-small cell Lung Cancer (NSCLC): A Phase II Study

라선영

January 1999

PURPOSE: To evaluate the efficacy and safety of gemcitabine, a pyrimidine antimetabolite against adv...

Cisplatin, Gemcitabine, and Vinorelbine Combination Therapy in Advanced Non–Small-Cell Lung Cancer: A Phase II Randomized Study of the Southern Italy Cooperative Oncology Group

Pasquale Comella
Nicola Panza
Luigi Manzione
Vito Lorusso
Gaetano Di Rienzo
Riccardo Cioffi
Luigi Maiorino
Domenico Bilancia
Gianpaolo Nicolella
Michele Natale
Franco Carpagnano
Carmen Pacilio
Mario De Lena
Andrea Bianco

October 2016

Purpose: In a previous phase I study cisplatin (CDDP), gemcitabine (GEM), and vinorelbine (VNR) comb...

A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIB/IV) non-small cell lung cancer

Chen, YM

[[abstract]]Study objective: Vinorelbine and gemcitabine are two active single agents used in the tr...

Original article

R. C. Lilenbaum
C. -s. Chen
T. Chidiac
P. O. Schwarzenberger
M. Thant
M. Versola
S. R. Lane

January 2004

Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanc...

Gemcitabine, vinorelbine, and cisplatin in the treatment of advanced nonsmall cell lung cancer

Hasturk S.
Hatabay N.
Ece F.
Karatasli M.
Hanta I.

January 2009

PubMedID: 19433960Objectives: Currently, cisplatin-based doublet combinations are accepted to be the...

Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: a multicenter phase II study.

Westeel, Virginie
Breton, J. L.
Braun, Daniel
Quoix, E.
Milleron, B.
Debieuvre, D.
Jacoulet, Pascale
Germa, C.
Kayitalire, L.
Depierre, A.

March 2006

International audienceIn this phase II study, gemcitabine and vinorelbine were combined at suboptima...

V. Lorusso
E. Crucitta
N. Panza
N. Silvestris
M. Guida
F. Carpagnano
S. Mancarella
D. Sambiasi
M. De Lena

January 2002

Background: The aim of our study was to determine the maximum tolerated dose of paclitaxel com-bined...

Combination chemotherapy of gemcitabine and vinorelbine for pretreated non-small- cell lung cancer: a retrospective study

Minami S
Ogata Y
Yamamoto S
Komuta K

September 2015

Seigo Minami, Yoshitaka Ogata, Suguru Yamamoto, Kiyoshi Komuta Department of Respiratory Medicine, O...

Clinical Trial Note A Phase II Study of Single-Agent Gemcitabine as a Second-Line Treatment in Advanced Non-Small Cell Lung Cancer

Yong Ho Roh
Seung-hyun Nam
Bong-seog Kim

January 2005

Objective: To evaluate the efficacy and safety of the single-agent gemcitabine in advanced non-small...

Efficacy of Gemcitabine Chemotherpy in Advanced Non-small cell Lung Cancer ( NSCLC ): A Phase 2 Study

김주항
노재경
장준

January 1999

PURPOSE: To evaluate the efficacy and safety of gemcitabine, a pyrimidine antimetabolite against adv...

Phase II study of gemcitabine and vinorelbine combination chemotherapy in patients with non-small-cell lung cancer not responding to previous chemotherapy

Chen, YM

[[abstract]]Both gemcitabine and vinorelbine are new anticancer drugs that have shown activity in th...

Oral vinorelbine and cisplatin as first-line therapy for advanced squamous NSCLC patients: a prospective randomized international phase II study (NAVoTrial 03)

Grossi F.
Jaskiewicz P.
Ferreira M.
Czyzewicz G.
Kowalski D.
Ciuffreda L.
Garcia-Gomez R.
Caruso S.
Bosch-Barrera J.
Gautier S.
Ta Thanh Minh C.
Henriet S.
de Castro G.

January 2021

Objective: The study investigated the efficacy and safety of oral vinorelbine-cisplatin (OV-CDDP) an...

Oral Vinorelbine for the Treatment of Metastatic Non-Small Cell Lung Cancer in Elderly Patients: A Phase II Trial of Efficacy and Toxicity.

Kanard, Anne
Jatoi, Aminah
Castillo, Rene
Geyer, Susan
Schulz, Thomas K
Fitch, Tom R, MD
Rowland, Kendrith M
Nair, Suresh G., MD
Krook, James E, MD
Kugler, John W, MD

March 2004

PURPOSE: Before now oral vinorelbine has not yet been tested in a cohort of elderly, advanced non-sm...

Phase II Study of Vinorelbine Plus Gemcitabine Options in Advanced Non-Small Cell Lung Cancer: A Review and Report on a doi: 10.1634/theoncologist.6-suppl_1-16

Rogerio Lilenbaum
Vinorelbine Plus Gemcitabine
Rogerio Lilenbaum
Key Words
Vinorelbine Gemcitabine
Lung Cancer

July 2015

located on the World Wide Web at: The online version of this article, along with updated information...

Original Articles Phase II Trial of Weekly Gemcitabine and Split-dose Cisplatin for Advanced Non-small-cell Lung Cancer

Atsushi Hiramatsu
Yoshinobu Iwasaki
Yasunori Koyama
Nobuyo Tamiya
Shigekuni Hosogi

January 2009

Objective: Cisplatin is widely used for the treatment of non-small-cell lung cancer. However, it can...

Efficacy of Gemcitabine Chemotherpy in Advanced Non-small cell Lung Cancer (NSCLC): A Phase II Study

라선영

January 1999

PURPOSE: To evaluate the efficacy and safety of gemcitabine, a pyrimidine antimetabolite against adv...

© 2000 Kluwer Academic Publishers. Printed in the Netherlands. Original article Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC):

Abstract

Extracted data

© 2000 Kluwer Academic Publishers. Printed in the Netherlands. Original article Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC):

Abstract

Extracted data

Related items

Related items